Viramune solution (Nevirapine)

Information about Viramune solution (Nevirapine)

Viramune Solution (Nevirapine) is a liquid form of Nevirapine, an antiretroviral medication used in the treatment of HIV/AIDS. It is particularly useful for patients who have difficulty swallowing tablets or for pediatric patients where dosing needs to be more precise. Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that blocks the action of reverse transcriptase, an enzyme that HIV uses to replicate.

Product Highlights

• It is used in the treatment of HIV-1, usually as part of combination antiretroviral therapy (cART) to reduce viral load.
• Nevirapine solution is also used in pregnant women with HIV to prevent the transmission of the virus to their babies during childbirth.

Key Ingredient

• Nevirapine

Key Benefits

• Nevirapine effectively lowers the viral load, helping to control HIV infection and preventing the progression to AIDS.
• The liquid form is ideal for children or adults who have trouble swallowing pills.
• Nevirapine helps in preventing the transmission of HIV from an infected mother to her baby during labor.
• By controlling viral replication, it helps to manage HIV infection and improves the life expectancy and health of those living with HIV.

Direction of Use

• Typically, the dosage starts at 200 mg once daily for the first 14 days and then increases to 200 mg twice daily, but this can vary based on the doctor’s instructions.
• The dosage is based on the child's weight and must be prescribed by a healthcare provider. The oral solution allows for more flexible dosing.
• The solution should be taken orally, either with or without food. It is important to shake the bottle well before each dose to ensure even distribution of the medication.
• It is crucial to take the medicine exactly as prescribed and not skip doses. Failing to take doses as scheduled can reduce the treatment's effectiveness. 

Safety Concerns

• Nevirapine can cause severe liver damage, particularly in the first few weeks of treatment. Liver function tests should be monitored closely, especially during the initial phase.
• Serious rashes, including Stevens-Johnson Syndrome, have been reported. If a rash develops, it is important to contact a healthcare provider immediately.
• Nevirapine may cause hypersensitivity reactions, including fever, swelling, or sore throat. These reactions should be addressed immediately.
• Nevirapine can interact with a number of medications, including birth control and other antiretroviral drugs. A healthcare provider should be consulted before starting any new medications.

Avoid Viramune Solution (Nevirapine) If

• Nevirapine should be avoided by individuals with moderate to severe liver dysfunction due to the risk of liver toxicity.
• It should not be used in people who have had a hypersensitivity reaction to Nevirapine or who have experienced severe skin reactions like Stevens-Johnson Syndrome.
• Nevirapine may be contraindicated in certain stages of pregnancy. It should be used only under close medical supervision in pregnant women.
• Careful monitoring and appropriate dosage adjustments should be made for children, especially those with liver issues, as they may be at increased risk of side effects.